Fiona Fordham

Learn More
OBJECTIVES:Chronic constipation is a common, persistent disorder with limited effective treatment options. This study investigated the efficacy, safety, and tolerability of tegaserod in the treatment of chronic constipation.METHODS:After a 2-wk baseline period, patients were randomized to double-blind treatment of 12 wk with tegaserod (2 or 6 mg b.i.d.) or(More)
BACKGROUND AND AIMS Chronic constipation is a common gastrointestinal disorder. The aim of this study was to evaluate the efficacy, safety, and tolerability of tegaserod, a serotonin subtype 4 receptor partial agonist in patients with chronic constipation. METHODS This was a randomized, double-blind, placebo-controlled study. After a 2-week baseline,(More)
criteria, pretesting questions, follow up and patient verification of accounts for accuracy. However, there was a disparity between patient and GP perception regarding the nature, severity and consequences of IBS in primary care, leading patients to perceive this interaction as a source of dissatisfaction. Disparity seems to lie with the physician, who(More)
criteria, pretesting questions, follow up and patient verification of accounts for accuracy. However, there was a disparity between patient and GP perception regarding the nature, severity and consequences of IBS in primary care, leading patients to perceive this interaction as a source of dissatisfaction. Disparity seems to lie with the physician, who(More)
  • 1